ST. LOUIS (AP) — Johnson & Johnson has been ordered to pay $55 million to a woman who claims its talcum powder caused her ovarian cancer, the second such judgment against the manufacturer in three months.
The ruling in St. Louis late Monday comes amid ongoing debate about the link between the bathroom staple and deadly disease that is often detected too late for treatment. Some studies suggest that women who regularly use talc face up to 40 percent higher risk of developing ovarian cancer. Meanwhile, New Jersey-based Johnson & Johnson cites other medical evidence showing its products such as Johnson's Baby Powder and Shower to Shower are blameless.
"Unfortunately, the jury's decision goes against 30 years of studies by medical experts around the world that continue to support the safety of cosmetic talc," Johnson & Johnson spokeswoman Carol Goodrich said in a statement announcing the company's plan to appeal.
Advertisement - story continues below